Coronavirus Disease 2019 (COVID-19) Impact on Immunology Trials – July 2020
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Since the beginning of March 2020, clinical trial operations were most disrupted as a result of the COVID-19 pandemic. This report summarizes the impact on immunology patient, clinical trial logistics, and key opinion leader (KOL) insights on the long-term impact of the pandemic.
Scope
Global overview of changes to clinical practice and clinical trial logistics in H1 2020 in 8MM (US, 5EU, Japan, Canada)
Summary of primary research with Immunology Key Opinion Leaders
Forward-looking perspective of potential long-term ramifications of COVID pandemic
Reasons to Buy
Understand the impact of COVID-19 on immunology clinical trials
Obtain a snapshot of the regulatory guidance issued by the US FDA, EMA, and Health Canada
Understand the impact of COVID on continuity of care for immunology patients
Understand the impact of COVID on clinical trial logistics (including trial recruitment, trial conduct, and supply chain)
Understand the potential long-term impact of COVID on clinical trial conduct and clinical practice
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.